Forgot username/password?
No account?
×
Ompliu els camps
Adreça electrònica a la qual voleu rebre la contrasenya
Telèfon de contacte (opcional)
Envia
×
IDIBAPS : Compte nou
Nom
Primer cognom
Segon cognom
DNI/Passaport/NIE/Altres
Adreça electrònica
Entitat d’adscripció
Seleccioneu
- (Grupo)
1.01.01 - Inflammatory joint diseases (IJDs) (Grupo)
1.02.00 - Systemic autoimmune diseases (Grupo)
1.02.01 - Systemic vasculitis (Grupo)
1.03.01 - Endocarditis. Cardiovascular infections. Experimental model (Grupo)
1.03.02 - Infections in solid-organ transplant recipients (Grupo)
1.03.03 - AIDS and HIV infection (Grupo)
1.03.04 - Nosocomial infection study group (Grupo)
1.04.01 - Immune receptors of the innate and adaptive system (Grupo)
1.05.01 - Musculoskeletal repair and plasticity (Grupo)
1.06.01 - Immunogenetics of the autoinflammatory response (Grupo)
1.07.01 - Emergencies: Processes and pathologies (Grupo)
1.08.01 - Molecular and cellular bases of inflammation. Structural and biological mass spectrometry (Grupo)
1.09.01 - Ocular Inflammation: Clinical and Experimental Studies (Grupo)
2.01.01 - Atherosclerosis, coronary disease and heart failure (Grupo)
2.02.00 - Arrhythmias, resynchronization and cardiac imaging (Grupo)
2.02.01 - Atrial Fibrillation Biopathology and Therapy (Grupo)
2.02.02 - Cardiac Imaging (Grupo)
2.02.03 - Vascular Cell Biology (Grupo)
2.02.04 - Arrythmias and Physical Activity (Grupo)
2.03.00 - Nephro-urological diseases and kidney transplantation (Grupo)
2.03.01 - Translational Research in Posttrasplant Neoplasia (Grupo)
2.04.01 - Cardiovascular, nutrition and aging unit (Grupo)
2.05.01 - Respiratory biophysics and bioengineering (Grupo)
2.06.00 - Applied research in infectious respiratory diseases, critically ill patients and lung cancer (Grupo)
2.06.01 - Breathing disturbances in sleep (Grupo)
2.07.00 - Physiopathological mechanisms of respiratory illnesses (Grupo)
2.07.01 - Translational research in pulmonary vascular diseases: cell proliferation and apoptotic mechanisms in pulmonary arterial hypertension (Grupo)
2.08.00 - Immunoal.lèrgia respiratòria clínica i experimental (IRCE) (Grupo)
2.08.01 - Sinonasal inflammatory and olfactory research group (Grupo)
2.09.01 - Inflammation and repair in respiratory illnesses (Grupo)
2.10.01 - Genetic and urological tumours (Grupo)
3.01.01 - Gynecological endocrinology and human reproduction (Grupo)
3.02.01 - Fetal and perinatal medicine (Grupo)
3.03.01 - Viral, toxic and metabolic hepatopathies (Grupo)
3.04.01 - Chronic liver diseases: molecular mechanisms and clinical consequences (Grupo)
3.04.02 - Translational research group in new therapeutic and diagnostic strategies in liver diseases (Grupo)
3.04.03 - Inflammation and liver disease (Grupo)
3.04.04 - Liver cell plasticity and tissue repair (Grupo)
3.05.00 - Hepatic oncology (Grupo)
3.05.01 - Translational research in hepatic oncology (Grupo)
3.05.02 - Hepatocelular signaling and cancer (Grupo)
3.06.01 - Regulation of liver microcirculation in cirrhosis and hepatic vascular diseases (Grupo)
3.06.02 - Angiogenesis in liver disease (Grupo)
3.06.03 - Liver vascular biology (Grupo)
3.07.01 - Inflammatory bowel disease (Grupo)
3.08.01 - Cholestasis (Grupo)
3.08.02 - Bone metabolic disease (Grupo)
3.09.01 - Mitochondrial regulation of cell death and steatohepatitis (Grupo)
3.10.00 - Liver transplantation and graft viability (Grupo)
3.10.01 - Protective strategies against hepatic ischemiareperfusion injury (Grupo)
3.11.00 - Gastrointestinal and pancreatic oncology (Grupo)
3.11.01 - Gene therapy and cancer group (Grupo)
3.11.02 - Genetic predisposition to colorectal cancer (Grupo)
3.12.01 - Inherited metabolic diseases (Grupo)
3.13.01 - Genomic programming of beta cells and diabetes (Grupo)
3.14.01 - Recerca translacional en Diabetes, lípids i Obesitat (Grupo)
3.14.03 - Pathogenesis and treatment of autoimmunity (Grupo)
3.14.04 - Endocrine disorders: crosstalk between molecular and metabolic determinants (Grupo)
3.14.05 - Neuronal control of metabolism (NEUCOME) (Grupo)
3.15.01 - Pathogenesis and prevention of diabetes (Grupo)
4.01.01 - Molecular neuropharmacology (Grupo)
4.01.02 - Systems neuropharmacology (Grupo)
4.01.03 - Neurotxicity and neurodegeneration mechanisms (Grupo)
4.01.04 - Cellular neurobiology (Grupo)
4.02.01 - Brain ischemia: Clinical and experimental studies (Grupo)
4.03.01 - Parkinson disease and other neurodegenerative movement disorders: clinical and experimental research (Grupo)
4.04.00 - Neurophysiology and functional studies of the nervous system (Grupo)
4.04.01 - Neurophysiology (Grupo)
4.05.01 - Muscle research and mitochondrial function (Grupo)
4.06.01 - Pathophysiology and treatment of neurodegenerative disorders (Grupo)
4.07.01 - Schizophrenia (Grupo)
4.07.02 - Bipolar disorders (Grupo)
4.07.03 - Child and adolescent psychiatry and psychology (Grupo)
4.07.04 - Multimodal neuroimaging in high risk and early psychosis (Grupo)
4.07.05 - Clinical addictions (Grupo)
4.08.01 - Neuropsychology (Grupo)
4.09.00 - Systems neuroscience (Grupo)
4.09.01 - Theoretical Neurobiology of Cortical Circuits (Grupo)
4.09.02 - Cortical Circuit Dynamics (Grupo)
4.10.01 - Pathogenesis of autoimmune neuronal disorders (Grupo)
4.10.02 - Pathogenesis and new treatments in multiple sclerosis (Grupo)
4.10.03 - Advanced imaging in neuroimmunological diseases (ImaginEM) (Grupo)
4.11.01 - Neurobiology Unit (Grupo)
4.12.01 - Alzheimer's disease and other cognitive disorders (Grupo)
5.01.01 - Molecular pathology of lymphoid neoplasms (Grupo)
5.01.02 - Molecular pathology of solid tumours (Grupo)
5.01.03 - Transcriptional regulation of gene expression (Grupo)
5.01.04 - Biomedical epigenomics (Grupo)
5.01.05 - Functional characterization of oncogenic mechanisms in lymphomagenesis (Grupo)
5.02.01 - Diagnosis and therapy in oncology (Grupo)
5.03.01 - Molecular Biology of reproduction and development (Grupo)
5.04.01 - Genetics (Grupo)
5.05.01 - Melanoma: imaging, genetics and immunology (Grupo)
5.06.01 - Hematopoietic progenitor cell transplantation (Grupo)
5.07.01 - Myeloid neoplasms (Grupo)
5.07.02 - Lymphoid neoplasms (Grupo)
5.07.03 - Myeloma and other monoclonal gammapathies (Grupo)
5.07.04 - Mechanisms of progession in monoclonal gammopathies (Grupo)
5.08.01 - Teràpies experimentals en neoplasies limfoides (Grupo)
5.08.02 - Microenvironment in lymphoma pathogenesis and therapy (Grupo)
5.09.01 - Hemotherapy - hemostasis (Grupo)
5.10.01 - Molecular and translational oncology (Grupo)
5.11.01 - Cell proliferation and signaling (Grupo)
5.12.01 - Endocytosis and intracellular trafficking of proteins and cholesterol (Grupo)
5.12.02 - Signal transduction and cell cycle (Grupo)
5.12.03 - Traffiking and disease (Grupo)
5.13.01 - Translational genomics and targeted therapeutics in solid tumors (Grupo)
T1.01 - Primary Healthcare Transversal Research Group (Grupo)
T2.01 - Research in nursing (Grupo)
T3.01 - Clinical pharmacology (Grupo)
Tipus d'adscripció
Seleccioneu
Investigadora
Categoria professional
Seleccioneu
Data d’inici de vinculació a l’entitat
Telèfon
Identificador en xarxa o base de dades científica
Tipus d’identificador
Codis d’identificació
ORCID
ResearcherID
Microsoft Academic Search
ResearchGate
Scopus Author ID
Academia.edu
Dialnet
Google Scholar
×
Compte nou
Envia
×
Formulari d’assistència
Envia
Drawings and photos by
Sagar
,
Lapin
,
Swasky
and
Guillem Trius
from
IDIBAPS Scientific Sketching
book
2016 ©
Development by iMarina Information System
©
IDIBAPS
.
Legal terms
. Contact:
support@idibaps.org
